Paul A Friedman's Net Worth

$265 Million

Who is Paul A Friedman?

Paul A Friedman has an estimated net worth of $265 Million. This is based on reported shares across multiple companies, which include MADRIGAL PHARMACEUTICALS, INC., Sirtris Pharmaceuticals, Inc., Prelude Therapeutics Inc, Verastem, Inc., Cerulean Pharma Inc., Durata Therapeutics, Inc., AUXILIUM PHARMACEUTICALS INC, ALEXION PHARMACEUTICALS INC, BAUSCH & LOMB INC, and INCYTE CORP.

SEC CIK

Paul A Friedman's CIK is 0001236927

Past Insider Trading and Trends

2014 was Paul A Friedman's most active year for acquiring shares with 23 total transactions. Paul A Friedman's most active month to acquire stocks was the month of April. 2015 was Paul A Friedman's most active year for disposing of shares, totalling 33 transactions. Paul A Friedman's most active month to dispose stocks was the month of March. 2015 saw Paul A Friedman paying a total of $8,403,941.68 for 604,520 shares, this is the most they've acquired in one year. In 2014 Paul A Friedman cashed out on 2,049,787 shares for a total of $66,346,814.02, their largest year based on trade value.